MME and acute lymphoblastic leukemia: Data analysis demonstrated that EV-CD10+ showed high performance (Se = 100.0% and Sp = 70.0%) and good global accuracy (AUC = 0.860 and p = 0.0065) to discriminate the B-ALL PB group from the control group.